Skip to Content
Merck
CN
  • Surgeon-administered conscious sedation and local anesthesia for ambulatory anorectal surgery.

Surgeon-administered conscious sedation and local anesthesia for ambulatory anorectal surgery.

The American surgeon (2014-01-10)
Miss Hina, Jon S Hourigan, Richard A Moore, J Daniel Stanley
ABSTRACT

Anorectal procedures are often performed in an outpatient setting using a variety of anesthetic techniques. One technique that has not been well studied is surgeon-administered conscious sedation along with local anesthetic. The purpose of this study was to evaluate the use of this technique with emphasis on safety, efficacy, and patient satisfaction. Chart review was performed on 133 consecutive patients who had anorectal procedures at an outpatient surgery center. Additionally, 65 patients were enrolled prospectively and completed a satisfaction survey. Inclusively, charts of 198 patients who underwent outpatient anorectal surgery under conscious sedation and local anesthesia under the direction of a colorectal surgeon from 2004 through 2008 were reviewed. Parameters related to patient and procedural characteristics, safety, efficacy, and satisfaction were evaluated. Surgeon-administered sedation consisted of combined fentanyl and midazolam in 90 per cent. Eighty per cent of procedures were performed in the prone position and 23 per cent were in combination with an endoscopic procedure. Eighty-two per cent were classified as American Society of Anesthesiologists Grade 1 or 2. Transient mild hypoxemia or hypotension occurred in 4 and 3 per cent of the patients, respectively. Mean operative time was 29 minutes with a mean stay in the postanesthesia care unit of 37 minutes. There were no early major cardiac or respiratory complications. Ninety-seven per cent of the patients surveyed reported a high degree of satisfaction. Surgeon-administered conscious sedation with local anesthesia was well tolerated for outpatient anorectal surgeries. Additional studies are needed to confirm the safety and efficacy of this technique.

MATERIALS
Product Number
Brand
Product Description

Supelco
Lidocaine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Lidocaine, European Pharmacopoeia (EP) Reference Standard
Supelco
Bupivacaine hydrochloride monohydrate, analytical standard, for drug analysis
Supelco
Lidocaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material
Lidocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Lidocaine hydrochloride monohydrate, solid
Supelco
Bupivacaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material